HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yangyang Yu Selected Research

Biomarkers (Surrogate Marker)

12/2022Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer.
1/2021Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
1/2019Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yangyang Yu Research Topics

Disease

15Neoplasms (Cancer)
05/2024 - 08/2016
6type 2C Congenital disorder of glycosylation
10/2022 - 01/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 12/2021
4Hypoxia (Hypoxemia)
12/2022 - 04/2019
4Stomach Neoplasms (Stomach Cancer)
11/2022 - 01/2020
3Inflammation (Inflammations)
08/2022 - 01/2018
2Triple Negative Breast Neoplasms
04/2024 - 08/2016
2Endometriosis
01/2023 - 10/2022
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2018
2Atopic Dermatitis (Atopic Eczema)
01/2020 - 12/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 01/2018
2Retinoblastoma (Glioblastoma, Retinal)
01/2018 - 07/2017
2Cardiotoxicity
06/2017 - 01/2016
1Mitochondrial Diseases (Mitochondrial Disease)
05/2024
1Poisoning
05/2024
1Dental Fluorosis
04/2024
1Fetal Growth Retardation (Intrauterine Growth Retardation)
12/2023
1Congenital Diaphragmatic Hernias
12/2023
1Thrombosis (Thrombus)
11/2023
1Necrosis
03/2023
1Carcinoma (Carcinomatosis)
01/2023
1Exanthema (Rash)
01/2023
1Adenocarcinoma of Lung
01/2023
1Intussusception
12/2022
1Intestinal Obstruction (Obstruction, Intestinal)
12/2022
1Melanoma (Melanoma, Malignant)
09/2022

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2016
4Interleukin-8 (Interleukin 8)IBA
10/2022 - 06/2016
3Phosphotransferases (Kinase)IBA
04/2024 - 12/2022
3Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2019
3CytokinesIBA
05/2022 - 12/2015
3anti-IgE antibodiesIBA
05/2022 - 01/2014
2Fluorouracil (Carac)FDA LinkGeneric
05/2024 - 11/2022
2CalciumIBA
04/2024 - 10/2022
2Glucose (Dextrose)FDA LinkGeneric
04/2024 - 01/2018
2Eosine Yellowish-(YS) (Eosin)IBA
04/2024 - 03/2023
2Hematoxylin (Haematoxylon)IBA
04/2024 - 03/2023
2RNA (Ribonucleic Acid)IBA
12/2023 - 01/2022
2Substance PIBA
10/2022 - 06/2016
2Circulating Tumor DNAIBA
01/2022 - 01/2021
2Folic Acid (Vitamin M)FDA LinkGeneric
11/2021 - 01/2018
2Messenger RNA (mRNA)IBA
01/2020 - 08/2016
2Toll-Like Receptor 2IBA
01/2020 - 12/2015
2Silicon Dioxide (Silica)FDA LinkGeneric
01/2018 - 07/2017
2CurcuminIBA
01/2018 - 01/2018
2Endothelin A ReceptorIBA
01/2018 - 08/2016
2Endothelin-1 (Endothelin 1)IBA
01/2018 - 08/2016
1AntioxidantsIBA
05/2024
1Acetylcysteine (Siran)FDA LinkGeneric
05/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024
1CCAAT-Enhancer-Binding Protein-deltaIBA
04/2024
1Vesicle-Associated Membrane Protein 3IBA
04/2024
1Paclitaxel (Taxol)FDA LinkGeneric
04/2024
1Inositol (Myoinositol)IBA
04/2024
1Activating Transcription Factor 6IBA
04/2024
1CalreticulinIBA
04/2024
1T16AInh-A01IBA
04/2024
1Endoplasmic Reticulum Chaperone BiPIBA
04/2024
1FluoridesIBA
04/2024
1Interleukin-6 (Interleukin 6)IBA
03/2023
1Toll-Like Receptor 4IBA
03/2023
1ImmunosorbentsIBA
03/2023
1Myeloid Differentiation Factor 88IBA
03/2023
1InterleukinsIBA
03/2023
1EnzymesIBA
03/2023
1CrizotinibIBA
01/2023
1tislelizumabIBA
01/2023
1Lactic Acid (Lactate)FDA LinkGeneric
01/2023
1Anaplastic Lymphoma KinaseIBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
01/2023
1ensartinibIBA
01/2023
1Capsules (Microcapsules)IBA
12/2022
1Activating Transcription Factor 4IBA
12/2022
1Alizarin Red SIBA
12/2022
1Protein Kinases (Protein Kinase)IBA
12/2022
1Immunotoxins (Immunotoxin)IBA
11/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2022
1Coloring Agents (Dyes)IBA
11/2022
1Single-Domain AntibodiesIBA
11/2022
1Cadherins (E-Cadherin)IBA
11/2022
1N-methyladenosineIBA
10/2022
1Indicators and Reagents (Reagents)IBA
09/2022
1Immune Checkpoint InhibitorsIBA
09/2022
1LipopolysaccharidesIBA
08/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2022
16-O-angeloylprenolinIBA
05/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
05/2022
1AllergensIBA
01/2022

Therapy/Procedure

4Immunotherapy
12/2022 - 08/2016
3Drug Therapy (Chemotherapy)
01/2021 - 01/2020
3Chemoradiotherapy
01/2021 - 01/2020
2Neoadjuvant Therapy
01/2022 - 01/2020
2Aftercare (After-Treatment)
01/2022 - 07/2017
1Extracorporeal Membrane Oxygenation
12/2023
1Embolic Protection Devices
11/2023
1Therapeutics
01/2023
1Conservative Treatment
12/2022